News Telix Pharmaceuticals Limited

Equities

TLX

AU000000TLX2

Delayed Australian S.E. Other stock markets 07:50:27 03/05/2024 am IST			5-day change	1st Jan Change
14.86 ^AUD	+0.41%		+3.81%	+47.27%

01:51am	Telix Pharmaceuticals Completes Acquisition of QSAM Biosciences and Drug Samarium-153-DOTMP	MT
30/04	Bell Potter Downgrades Telix Pharmaceuticals to Hold from Buy, Price Target is AU$14.50	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Telix Pharmaceuticals Completes Acquisition of QSAM Biosciences and Drug Samarium-153-DOTMP	05:21am	MT
Telix to Showcase Extensive Urologic Pipeline at AUA Annual Meeting including Phase III ProstACT GLOBAL Study of TLX591	01/05	AQ
Bell Potter Downgrades Telix Pharmaceuticals to Hold from Buy, Price Target is AU$14.50	30/04	MT
Telix - Notice of Annual General Meeting 2024	22/04	AQ
Jarden Adjusts Telix Pharmaceuticals Price Target to AU$13.52 from AU$13.27, Keeps at Buy	18/04	MT
Q1 2024 Revenue and Business Update	17/04	AQ
Telix Pharmaceuticals Limited Reports Unaudited Revenue Results for the First Quarter Ended 31 March 2024	17/04	CI
Telix Pharmaceuticals Limited Reaffirms Revenue Guidance for the Year 2024	17/04	CI
Telix Pharmaceuticals Logs Nearly $115 Million Revenue in Q1	17/04	MT
Telix Pharmaceuticals Secures US FDA Fast-Track Designation for Brain Cancer Imaging Product	16/04	MT
TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation	16/04	AQ
Telix Pharmaceuticals Limited Announces FDA Fast Track Designation for TLX101-CDx	16/04	CI
Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.	11/04	BU
Telix Pharmaceuticals Completes Acquisition of Canadian Firm ARTMS	11/04	MT
Telix Pharmaceuticals Limited completed the acquisition of ARTMS, INC.	11/04	CI
Telix Pharmaceuticals Completes Acquisition of IsoTherapeutics Group	09/04	MT
Telix Pharmaceuticals Limited completed the acquisition of IsoTherapeutics Group, LLC for $8.1 million.	09/04	CI
Telix Pharmaceuticals - World First Use of Lightpoint's SENSEI Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain	27/03	AQ
World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain	27/03	AQ
Telix Pharmaceuticals Limited Announces First Patient Dosed in Italian Named Patient ( Early Access) Program for TLX250-CDx Telix's Kidney Cancer Imaging Agent	25/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Telix Pharmaceuticals Limited

Equities

TLX

AU000000TLX2

Summary

Filters